Compounds isolated from Euonymus spraguei Hayata induce ossification through multiple pathways

Zuha Imtiyaz,Yi-Tzu Lin,Ut-Hang Cheong,Alagie Jassey,Hui-Kang Liu,Mei-Hsien Lee

DOI: https://doi.org/10.1016/j.sjbs.2020.06.036

IF: 4.052

2020-09-01

Saudi Journal of Biological Sciences

Abstract:Process of bone metabolism includes the catabolism of old or mature bone and anabolism of new bone, carried out by osteoclasts and osteoblasts respectively. Any imbalance in this process results in loss of bone mass or osteoporosis. Drugs available to combat osteoporosis have certain adverse effects and are unable to improve bone formation, hence identification of new agents to fulfil these therapeutic gaps is required. To expand the scope of potential agents enhancing bone formation, we identified <em>Euonymus spraguei</em> Hayata as a plant material that possesses robust osteogenic potential using human osteoblast cells. We isolated three compounds, syringaresinol (<strong>1</strong>), syringin (<strong>2</strong>), and (-)-epicatechin (<strong>3</strong>), from <em>E. spraguei.</em> Results demonstrated that syringrin (<strong>2</strong>), and (-)-epicatechin (<strong>3</strong>), increased the alkaline phosphatase activity significantly up to 131.01% and 130.67%, respectively, they also elevated the mineral deposition with respective value up to 139.39% and 138.33%. In addition, <strong>2</strong> and <strong>3</strong> modulated autophagy and bone morphogenetic protein-2 (BMP-2) signaling pathway. Our findings demonstrated that <strong>2</strong> and <strong>3</strong> induced osteogenesis by targeting multiple pathways and therefore can be considered as potent multi-targeted drugs for bone formation against osteoporosis.

biology